Rheumatoid patients with wrist synovitis, if prescribed wrist splints do better in terms of grip strength, than if not prescribed
ISRCTN | ISRCTN59145515 |
---|---|
DOI | https://doi.org/10.1186/ISRCTN59145515 |
Secondary identifying numbers | N0236177886 |
- Submission date
- 29/09/2006
- Registration date
- 29/09/2006
- Last edited
- 26/10/2016
- Recruitment status
- No longer recruiting
- Overall study status
- Completed
- Condition category
- Musculoskeletal Diseases
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Record updated in last year
Plain English summary of protocol
Not provided at time of registration
Contact information
Mrs Margaret Sibley
Scientific
Scientific
St George's NHS Trust
Blackshaw Road
London
SW17 0QT
United Kingdom
Phone | +44 (0)20 8725 1848 |
---|---|
margaret.sibley@stgeorges.nhs.uk |
Study information
Study design | Randomised controlled trial |
---|---|
Primary study design | Interventional |
Secondary study design | Randomised controlled trial |
Study setting(s) | Not specified |
Study type | Not Specified |
Scientific title | Rheumatoid patients with wrist synovitis, if prescribed wrist splints do better in terms of grip strength, than if not prescribed |
Study objectives | To explore whether the prescribing of wrist splints for wrist swelling in patients with rheumatoid arthritis, improves grip strength (function), compared to patients not prescribed splints. Wrist splints are prescribed on a daily basis in rheumatology clinics and it is not known whether there is any significant benefit obtained from their use. Hopefully the outcome of the study will provide evidence based information on the effectiveness of wrist splints for treating wrist swelling. |
Ethics approval(s) | Not provided at time of registration |
Health condition(s) or problem(s) studied | Rheumatoid arthritis (RA) |
Intervention | The purpose of this research project is to explore the effectiveness of wrist splints when prescribed for swelling of the wrist. A quantitative design will be used, as the outcome will rely on numerical data statistically analysed. The plan is to recruit 40 patients from the rheumatology clinics who will have been examined by their physician and clinically diagnosed with swelling of the wrist. All patients eligible to take part in the study will be asked to complete the Grip Ability Test (GAT). This is a reliable and validated outcome measure to determine grip strength. The groups receiving the standard splints and the dummy splints need to be as similar as possible and so there should be equal numbers of GAT positive and GAT negative in each group. 30 patients will be randomised to receive standard rheumatoid splints and 20 patients to receive elastic dummy wrist splints. The randomisation will be achieved as follows: Stratified randomisation: Patients will be stratified according to the outcome of the GAT test into 2 groups (GAT positive and GAT negative). Those two groups will then be assigned to treatment or dummy according to a computer generated randomisation (We have sought a statisticians advice regarding the randomisation). The study will be a two treatment, two period, cross over study carried out over 6 months (3 months with a standard splint then 3 months with a dummy splint and vice versa). (If after 3 months there is a statistically significant benefit from the treatment arm, the study will of course be discontinued). |
Intervention type | Other |
Primary outcome measure | To explore whether the prescribing of wrist splints for wrist swelling in patients with rheumatoid arthritis, improves grip strength (function), compared to patients not prescribed wrist splints. |
Secondary outcome measures | Not provided at time of registration |
Overall study start date | 28/02/2006 |
Completion date | 14/12/2006 |
Eligibility
Participant type(s) | Patient |
---|---|
Age group | Adult |
Lower age limit | 18 Years |
Sex | Both |
Target number of participants | 40 |
Key inclusion criteria | 1. Stable DMARDs (disease modifying anti-rheumatic drugs) for the preceding month (to ensure patients are not experiencing any known side effects to the prescribed medication) 2. Male/Female 18 years of age or over (children not seen in department) 3. Confirmed diagnosis of rheumatoid arthritis 4. Disease duration >1 year (disease process confirmed) 5. Clinically diagnosed synovitis (swelling) of the wrist 6. Able to read, understand and complete consent form and questionnaire (as the patient will be seen in clinic and expected to complete them whilst in clinic) 7. Able to wear splints as directed (as the patient will need to fit and remove splints themselves) Patients will be attending their routine follow up rheumatology clinic and seen by their clinician. Any patient presenting with a swollen wrist who has been prescribed a wrist splint by their clinician, will be invited to speak to the researcher and the purpose of the trial fully explained. All the rheumatology clinicians in the department will be made aware of the study and will be kept informed of its progress throughout, in order to aid identification of patients. The patients will be given the appropriate written information and asked to read whilst in clinic. The researcher will be available at that time to discuss any queries. If the patients fully meet the criteria and have agreed to enrol on the trial they will be seen by an assistant and randomised to receive a standard splint or dummy splint. If they are not sure, or need more time to decide, they will be able to take all the information home and will be contacted the next day for their decision. This is to ensure that treatment is started as soon as possible regardless of whether they are involved in the trial or not. |
Key exclusion criteria | 1. Previous wrist or hand surgery 2. Severe deformity of the wrist or hand 3. Previous injury or fracture of the wrist or hand and disease duration < 1 year. |
Date of first enrolment | 28/02/2006 |
Date of final enrolment | 14/12/2006 |
Locations
Countries of recruitment
- England
- United Kingdom
Study participating centre
St George's NHS Trust
London
SW17 0QT
United Kingdom
SW17 0QT
United Kingdom
Sponsor information
Record Provided by the NHSTCT Register - 2006 Update - Department of Health
Government
Government
The Department of Health, Richmond House, 79 Whitehall
London
SW1A 2NL
United Kingdom
Phone | +44 (0)20 7307 2622 |
---|---|
dhmail@doh.gsi.org.uk | |
Website | http://www.dh.gov.uk/Home/fs/en |
Funders
Funder type
Government
St George's Healthcare NHS Trust
No information available
No External Funding
No information available
NHS R&D Support Funding
No information available
Results and Publications
Intention to publish date | |
---|---|
Individual participant data (IPD) Intention to share | No |
IPD sharing plan summary | Not provided at time of registration |
Publication and dissemination plan | Not provided at time of registration |
IPD sharing plan |
Editorial Notes
26/10/2016: No publications found, verifying study status with principal investigator